Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType <span class='defaultText'>DefinitionDescription</span> dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
52785-3 Maximum lysis.extrinsic coagulation system activated.fibrinolysis suppressed LenFr Bld Pt Qn Thromboelastography.rotational &nbsp; ACTIVE Maximum lysis.extrinsic coagulation system activated.fibrinolysis suppressed [Length fraction] in Blood by Rotational TEG &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % 90% &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; COAG &nbsp; 52785-3 &nbsp; Thromboelastography.rotational &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ML.fibrinolysis supp LenFr Bld ROTEM &nbsp; &nbsp; &nbsp; N &nbsp; Activ; Blood; Coag; Hematology; Heme; Length Fraction; ML; ML.extrinsic; ML.fibrinolysis supp; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; ROTEM; TEG; TEM; Thrombelastography; Thrombelastometry; Thromboelastometry; WB; Whole blood 2.73 2.24 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Updated Method from Thromboelastography to clarify that the Method used for this assay is rotational TEG ("ROTEM") and to distinguish from the original thromboelastography and new resonance thromboelastography Methods. 0
52786-1 Maximum lysis.extrinsic coagulation system activated LenFr Bld Pt Qn Thromboelastography.rotational &nbsp; ACTIVE Maximum lysis.extrinsic coagulation system activated [Length fraction] in Blood by Rotational TEG &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % 90% &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; COAG &nbsp; 52786-1 &nbsp; Thromboelastography.rotational &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ML.extrinsic LenFr Bld ROTEM &nbsp; &nbsp; &nbsp; N &nbsp; Activ; Blood; Coag; Hematology; Heme; Length Fraction; ML; ML.extrinsic; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; ROTEM; TEG; TEM; Thrombelastography; Thrombelastometry; Thromboelastometry; WB; Whole blood 2.73 2.24 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Updated Method from Thromboelastography to clarify that the Method used for this assay is rotational TEG ("ROTEM") and to distinguish from the original thromboelastography and new resonance thromboelastography Methods. 0
52787-9 Maximum lysis.intrinsic coagulation system activated LenFr Bld Pt Qn Thromboelastography.rotational &nbsp; ACTIVE Maximum lysis.intrinsic coagulation system activated [Length fraction] in Blood by Rotational TEG &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % 80% &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; COAG &nbsp; 52787-9 &nbsp; Thromboelastography.rotational &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ML.intrinsic LenFr Bld ROTEM &nbsp; &nbsp; &nbsp; N &nbsp; Activ; Blood; Coag; Hematology; Heme; Length Fraction; ML; ML.intrinsic; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; ROTEM; TEG; TEM; Thrombelastography; Thrombelastometry; Thromboelastometry; WB; Whole blood 2.73 2.24 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Updated Method from Thromboelastography to clarify that the Method used for this assay is rotational TEG ("ROTEM") and to distinguish from the original thromboelastography and new resonance thromboelastography Methods. 0
52788-7 Maximum lysis.intrinsic coagulation system activated.heparin insensitive LenFr Bld Pt Qn Thromboelastography.rotational &nbsp; ACTIVE Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG &nbsp; MIN DefinitionDescription &nbsp; &nbsp; % 90% &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; COAG &nbsp; 52788-7 &nbsp; Thromboelastography.rotational &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 ML.heparin insens LenFr Bld ROTEM &nbsp; &nbsp; &nbsp; N &nbsp; Activ; Blood; Coag; Hematology; Heme; Hep; Hepar; Heparn; Length Fraction; ML; ML.heparin insens; ML.intrinsic; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; ROTEM; TEG; TEM; Thrombelastography; Thrombelastometry; Thromboelastometry; WB; Whole blood 2.7 2.24 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; % &nbsp; &nbsp; Updated Method from Thromboelastography to clarify that the Method used for this assay is rotational TEG ("ROTEM") and to distinguish from the original thromboelastography and new resonance thromboelastography Methods. 0
52789-5 Clot initiation Time Bld Pt Qn Thromboelastography &nbsp; ACTIVE Clot initiation [Time] in Blood by Thromboelastography &nbsp; MIN DefinitionDescription &nbsp; &nbsp; s 300 sec &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; COAG &nbsp; 52789-5 &nbsp; Thromboelastography &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Clot init Bld TEG &nbsp; &nbsp; &nbsp; N &nbsp; Blood; COAGULATION; Hematology; Heme; Point in time; QNT; Quan; Quant; Quantitative; Random; TEG; Thrombelastography; Thrombelastometry; WB; Whole blood 2.73 2.24 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; s &nbsp; &nbsp; Release 2.70: COMPONENT: Updated from "Clotting time" to more accurately represent what is being measured; Release 2.67: ORDER_OBS: Updated Order_Obs from "Observation" to "Both" 0
5279-5 Plasmodium sp Ab ACnc Ser Pt Qn &nbsp; &nbsp; ACTIVE Plasmodium sp Ab [Units/volume] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 5279-5 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Plasmodium Ab Ser-aCnc &nbsp; &nbsp; &nbsp; Y &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Malaria; Malarial; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR 2.69 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U]/mL &nbsp; &nbsp; &nbsp; 0
52790-3 Guidance for percutaneous replacement of drainage catheter Find Abdomen Pt Doc CT &nbsp; ACTIVE CT Guidance for percutaneous replacement of drainage catheter of Abdomen &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; RAD &nbsp; 52790-3 &nbsp; CT &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 CT Guided Abd PC drain cath replace &nbsp; &nbsp; &nbsp; N &nbsp; Abd; Abdo; Abdomen+; Abdominal; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; PC drain cath replace; Perc; Point in time; Rad; RADIOLOGY; Random; Removal of fluid 2.68 2.24 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.68: COMPONENT: Updated "drainage tube" to "drainage catheter", the preferred name in the LOINC/RadLex unified model.; Previous Releases: The scale has been changed from "Nar" to "Doc" to fit with the CDA model.;Updated component from "Guidance for replacement of percutaneous drainage tube" based on LOINC/Radlex unified model 0
52791-1 Guidance for percutaneous replacement of drainage catheter Find Pelvis Pt Doc CT &nbsp; ACTIVE CT Guidance for percutaneous replacement of drainage catheter of Pelvis &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; RAD &nbsp; 52791-1 &nbsp; CT &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 CT Guided Pelvis PC drain cath replace &nbsp; &nbsp; &nbsp; N &nbsp; CAT scan; Cath; Computed tomography; Computerized tomography; CT scan; Document; Drain; Exudate; Finding; Findings; Guid; Guide; Guided; Imaging; PC drain cath replace; Pelvic; Perc; Point in time; Rad; RADIOLOGY; Random; Removal of fluid 2.68 2.24 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.68: COMPONENT: Updated "drainage tube" to "drainage catheter", the preferred name in the LOINC/RadLex unified model.; Previous Releases: The scale has been changed from "Nar" to "Doc" to fit with the CDA model.; Updated Component from "Guidance for replacement of percutaneous drainage tube" based on LOINC/RadLex unified model 0
52792-9 Rh Type Bld^Father Pt Nom &nbsp; &nbsp; ACTIVE Father's Rh Type &nbsp; MAJ DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 52792-9 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Rh Bld Father &nbsp; &nbsp; &nbsp; N &nbsp; Blood; BLOOD BANK; D phenotyping; D typing; Hematology; Heme; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood 2.61 2.24 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
52793-7 ABO group Type Bld^Father Pt Nom &nbsp; &nbsp; ACTIVE Father's ABO group Type &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; BLDBK &nbsp; 52793-7 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 ABO Group Bld Father &nbsp; &nbsp; &nbsp; N &nbsp; Blood; BLOOD BANK; Hematology; Heme; Nominal; Point in time; Random; Typ; WB; Whole blood 2.72 2.24 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
52794-5 Ova & parasites^3rd specimen Prid XXX Pt Nom Microscopy.light &nbsp; ACTIVE Ova and parasites identified in Specimen by Light microscopy--3rd specimen &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 52794-5 &nbsp; Microscopy.light &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 O+P sp3 Spec Micro &nbsp; &nbsp; &nbsp; N &nbsp; ID; Identity or presence; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; Misc; Miscellaneous; Nominal; O&P; O+P; Other; Ova and parasite; Ovum; Parasite; Point in time; Random; sp3; Spec; To be specified in another part of the message; Unspecified 2.78 2.24 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; Previous Releases: Changed model to make term consistent with other terms 0
52795-2 Ova & parasites^2nd specimen Prid XXX Pt Nom Microscopy.light &nbsp; ACTIVE Ova and parasites identified in Specimen by Light microscopy--2nd specimen &nbsp; NAM DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 52795-2 &nbsp; Microscopy.light &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 O+P sp2 Spec Micro &nbsp; &nbsp; &nbsp; N &nbsp; Convalescent; ID; Identity or presence; Infectious Disease; InfectiousDisease; LM; Micro; Microbiology; Micros; Microscopic; Misc; Miscellaneous; Nominal; O&P; O+P; Other; Ova and parasite; Ovum; Parasite; Point in time; Post immunization; Random; Second; sp2; Spec; To be specified in another part of the message; Unspecified 2.78 2.24 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; Previous Releases: Changed model to make term consistent with other terms 0
52796-0 Planned stop date Date Medication.current Pt Qn &nbsp; &nbsp; DISCOURAGED Planned stop date Current medication &nbsp; MIN DefinitionDescription &nbsp; &nbsp; MMDDYY &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CARE &nbsp; 52796-0 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; CARE Survey; Med; Point in time; QNT; Quan; Quant; Quantitative; Random; Survey 2.64 2.26 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
52797-8 Diagnosis ICD code Prid ^Patient Pt Nom &nbsp; &nbsp; ACTIVE Diagnosis ICD code [Identifier] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; CLIN &nbsp; 52797-8 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 Dx ICD code &nbsp; &nbsp; &nbsp; N &nbsp; CLIN; Dx; Dx ICD code; Identity or presence; International Classification of Diseases; Nominal; Point in time; Random 2.73 2.26 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Changed CLASS from SURVEY.MDS to CLIN 0
52798-6 Medical coding diagnosis, comorbidity, and complication list is complete Find ^Patient Pt Ord CARE &nbsp; DEPRECATED Deprecated Medical coding diagnosis, comorbidity, and complication list is complete &nbsp; DEL DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CARE &nbsp; 52798-6 &nbsp; CARE &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; CARE I.b16 Is this list complete? N &nbsp; CARE Survey; Continuity assessment record and evaluation; Dx; Finding; Findings; Medical coding Dx, comorbidity, and complication list is complete; Ordinal; Point in time; QL; Qual; Qualitative; Random; Screen; Survey 2.36 2.26 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
52799-4 Major treatments used on or 1D prior to day of death panel - ^Patient Pt - &nbsp; &nbsp; ACTIVE Major treatments used on or 1 day prior to day of death panel &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CARE &nbsp; 52799-4 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; CARE Survey; Continuity Assessment Record and Evaluation (CARE) Pnl; Major Txs; Major Txs used on or 1D prior to day of death; Major Txs used on or 1D prior to day of death panel; Pan; Panl; Pnl; Point in time; Random; Survey; Tx; Txs 2.48 2.26 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
528-0 Viomycin Susc Isolate Pt OrdQn MIC &nbsp; ACTIVE Viomycin [Susceptibility] by Minimum inhibitory concentration (MIC) &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ABXBACT &nbsp; 528-0 &nbsp; MIC &nbsp; &nbsp; Observation &nbsp; &nbsp; &nbsp; 0 Viomycin Islt MIC &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; ANTIBIOTIC SUSCEPTIBILITIES; AST; ID; Infectious Disease; InfectiousDisease; Islt; Isol; Minimum inhibitory concentration; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Tuberactinomycin b 2.19 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
5280-3 Plasmodium vivax Ab ACnc Ser Pt Qn &nbsp; &nbsp; ACTIVE Plasmodium vivax Ab [Units/volume] in Serum &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; MICRO &nbsp; 5280-3 &nbsp; &nbsp; &nbsp; &nbsp; Both &nbsp; &nbsp; &nbsp; 0 P vivax Ab Ser-aCnc &nbsp; &nbsp; &nbsp; Y &nbsp; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Malaria; Malarial; Microbiology; P vivax; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR 2.69 1 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; [arb'U]/mL &nbsp; &nbsp; &nbsp; 0
52800-0 Major treatments used on or 1D prior to day of death Find ^Patient Pt Nom CARE &nbsp; DISCOURAGED Major treatments used on or 1 day prior to day of death [CARE] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CARE &nbsp; 52800-0 &nbsp; CARE &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Major Txs; Major Txs used on or 1D prior to day of death; Nominal; Point in time; Random; Survey; Tx; Txs 2.64 2.26 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
52801-8 Major treatments admitted with panel - ^Patient Pt - &nbsp; &nbsp; ACTIVE Major treatments admitted with panel &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CARE &nbsp; 52801-8 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; CARE Survey; Continuity Assessment Record and Evaluation (CARE) Pnl; Major Txs; Major Txs admitted with; Major Txs admitted with panel; Pan; Panl; Pnl; Point in time; Random; Survey; Transferred; Tx; Txs 2.48 2.27 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0
52802-6 Major treatments admitted with Find ^Patient Pt Nom CARE &nbsp; DISCOURAGED Major treatments admitted with [CARE] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CARE &nbsp; 52802-6 &nbsp; CARE &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Major Txs; Major Txs admitted with; Nominal; Point in time; Random; Survey; Transferred; Tx; Txs 2.64 2.27 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
52803-4 Major treatments discharged with panel - ^Patient Pt - &nbsp; &nbsp; DISCOURAGED Major treatments discharged with panel &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CARE &nbsp; 52803-4 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; CARE Survey; Continuity Assessment Record and Evaluation (CARE) Pnl; Major Txs; Major Txs discharged with; Major Txs discharged with panel; Pan; Panl; Pnl; Point in time; Random; Survey; Tx; Txs 2.64 2.27 &nbsp; Panel &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
52804-2 Major treatments discharged with Find ^Patient Pt Nom CARE &nbsp; DISCOURAGED Major treatments discharged with [CARE] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CARE &nbsp; 52804-2 &nbsp; CARE &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Major Txs; Major Txs discharged with; Nominal; Point in time; Random; Survey; Tx; Txs 2.64 2.27 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
52805-9 Major treatments used within 2D interim period panel - ^Patient 2D - &nbsp; &nbsp; DISCOURAGED Major treatments used within 2 days interim period panel &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; PANEL.SURVEY.CARE &nbsp; 52805-9 &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 2 days; 48 hours; CARE Survey; Continuity Assessment Record and Evaluation (CARE) Pnl; Major Txs; Major Txs used within 2D interim period; Major Txs used within 2D interim period panel; Pan; Panl; Pnl; Survey; Tx; Txs 2.64 2.26 &nbsp; Panel &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
52806-7 Major treatments used within 2D interim period Find ^Patient 2D Nom CARE &nbsp; DISCOURAGED Major treatments used within 2 days interim period [CARE] &nbsp; MIN DefinitionDescription &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; SURVEY.CARE &nbsp; 52806-7 &nbsp; CARE &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 0 &nbsp; &nbsp; &nbsp; &nbsp; N &nbsp; 2 days; 48 hours; CARE Survey; Continuity assessment record and evaluation; Finding; Findings; Major Txs; Major Txs used within 2D interim period; Nominal; Survey; Tx; Txs 2.64 2.26 &nbsp; &nbsp; &nbsp; AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
104,672 results found